On this week’s episode of Managed Care Cast, we're discussing a significant advancement in health care: the May 16 FDA approval of the first blood tes...

An enhanced dermatologic management (DM) strategy, COCOON DM, significantly reduced the incidence and severity of dermatologic adverse events (AEs) am...

More than 2 decades after policy discussions began promoting the idea of “value-based care,” reimbursement systems have failed to keep pace with the a...

The treatment landscape of non–small cell lung cancer (NSCLC) harboring EGFR mutations has undergone profound evolution over the past 2 decades. Begin...

ABSTRACT Objective: To evaluate the relationship between the frequency of routine primary care visits and total health care expenditures among commerc...

Uncommon EGFR mutations, such as exon 20 insertions, compound variants, and P-loop αC-helix compressing (PACC) alterations, account for nearly one-thi...

Using body mass index (BMI) alone to screen for pediatric obesity accurately identified excess adiposity in nearly all children and adolescents with o...

Managing multiple sclerosis (MS) is already complex, but for the approximately 5% of people with MS who also live with another chronic inflammatory co...

Cemiplimab monotherapy provided durable survival benefits compared with chemotherapy for people with advanced non–small cell lung cancer (NSCLC) whose...

New research published in Transfusion1 shows that decreasing the deferral period for blood donation in those with high-risk behaviors, such as injecti...